GlassScriptPhysician profile
Becky J Coyner
NPI 1023391588
$3,498.56
in general payments reported to CMS, 2019-2025
18 companies · $836 in 2025
The $836 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $705 · 2022: $338 · 2023: $1,027 · 2024: $593 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,451 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,450.94 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $679.88 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $466.99 | 2023-2025 | Gemtesa |
| C. R. Bard, INC. & Subsidiaries | $450.59 | 2023-2025 | Bard Urinary Drainage Bag |
| Olympus America INC. | $393.25 | 2023-2025 | Itind System |
| Astellas Pharma US INC | $328.41 | 2021-2023 | Veozah |
| Antares Pharma, INC. | $316.54 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Coloplast Corp | $231.59 | 2024-2025 | |
| Teleflex LLC | $147.75 | 2021-2023 | Urolift |
| Endo Pharmaceuticals INC. | $124.85 | 2023 | Xiaflex |
| Tolmar, INC. | $84.66 | 2023-2025 | Jatenzo, Eligard |
| Becton, Dickinson and Company | $78.21 | 2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Verity Pharmaceuticals INC. | $53.75 | 2025 | Tlando |
| Convatec INC. | $39.69 | 2024 | |
| Axonics, INC. | $32.70 | 2024 | Axonics |
| 180 Medical, INC. | $18.94 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $18.90 | 2024 | |
| Endo USA, INC. | $17.72 | 2025 | Xiaflex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.14 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Becky Coyner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.